Healwell AI (AIDX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
2 Jul, 2026Executive summary
Achieved record Q4 2024 revenue of CAD 15.2 million (up 692% year-over-year) and gross profit of CAD 7 million (up 1,179% year-over-year), driven by acquisitions and AI commercialization.
Full-year 2024 revenue reached CAD 39 million, with four strategic acquisitions completed and the transformative Orion Health acquisition announced, expected to close April 1, 2025.
Orion Health acquisition will add over CAD 100 million in annual revenue and make the company EBITDA-positive, expanding global reach and SaaS recurring revenue.
Signed 30 master service agreements with life sciences partners, including seven of the top 10 global pharma companies.
Growth driven by acquisitions of Intrahealth Solutions, VeroSource Solutions, Bio Pharma Services, Mutuo Health Solutions, and expansion in life sciences partnerships.
Financial highlights
Fiscal 2024 revenue from continuing operations was CAD 39 million, up from CAD 7.3 million in 2023.
Gross profit for 2024 was CAD 17 million (44% margin), up from CAD 1.2 million (17% margin) in 2023.
Q4 2024 revenue was CAD 15.2 million (up 692% year-over-year); gross profit was CAD 7 million (46% margin).
Adjusted EBITDA loss for 2024 was CAD 16 million; Q4 2024 adjusted EBITDA loss was CAD 5.5 million.
Ended Q4 2024 with CAD 9.4 million in cash; subsequent financings raised over CAD 100 million for acquisitions and liquidity.
Outlook and guidance
Orion Health acquisition expected to close April 1, 2025, adding over CAD 100 million in annual revenue and driving EBITDA profitability.
2025 guidance: AI/data science revenue expected to double, healthcare software to approach CAD 100 million, and clinical research to grow by 50%.
Gross margin expected to reach 50% on a blended basis post-Orion acquisition.
Focus on integrating Orion Health, executing disciplined M&A, and expanding Buy Canadian opportunities.
Cost optimization initiatives expected to yield at least CAD 3 million in annual savings.
Latest events from Healwell AI
- Q1 revenue up 208% year-over-year; Orion Health acquisition to add CAD 100M annual revenue.AIDX
Q1 20259 Jul 2026 - Record Q3 revenue and major acquisitions drive rapid growth and target CAD 100M run rate in 2025.AIDX
Q3 20248 Jul 2026 - Q1 revenue rose 316% to CAD 33.2M, with positive adjusted EBITDA and expanding global AI adoption.AIDX
Q1 20268 May 2026 - Record 2025 revenue and first positive Adjusted EBITDA highlight rapid AI and software growth.AIDX
Q4 202520 Mar 2026 - Q2 revenue up 204% to CAD 5.44M; profitability and AI launches drive strong outlook.AIDX
Q2 20241 Feb 2026 - Record revenue growth and first positive EBITDA mark a strategic shift to pure-play AI software.AIDX
Q2 202523 Nov 2025 - Q3 revenue jumped 354% to CAD 30.4M, with positive Adjusted EBITDA and global AI expansion focus.AIDX
Q3 20257 Nov 2025